Diabetic Macular Edema MarketThe global diabetic macular edema market is on a steady growth trajectory, with an expected valuation of approximately USD 4,120.9 million in 2024. The market is poised to ...

Oral Controlled Release Drug Delivery Technology MarketThe global market for oral controlled release drug delivery technology is poised for significant growth, with sales expected to double from USD ...

MRI-Compatible IV Infusion Pump Systems MarketThe global market for MRI-compatible IV infusion pump systems is set for significant expansion, driven by advancements in medical imaging and increasing ...

Cold Chain Technologies (CCT) and Tower Cold Chain, a subsidiary of CCT, have reached important milestones in their ongoing ...

Moderna, Inc. (NASDAQ:MRNA) has announced updates demonstrating substantial R&D investment and progress in the UK, two years ...

Long COVID patient finds hope, and help through The Spero Clinic's neurological relief program. FAYETTEVILLE, ARKANSAS / ACCESS Newswire / February 3, 2025 / In a world plagued by chronic and ...

China’s First Aid MarketThe China first aid market, valued at USD 266.5 million in 2014, is projected to grow at a compound annual growth rate (CAGR) of 6.3% over the forecast period. Basic first aid ...

High Content Screening MarketThe global high content screening (HCS) market is poised for steady expansion, with its valuation expected to reach USD 1.6 billion in 2022 and a projected compound annual ...

ATLANTA, GA / ACCESS Newswire / February 3, 2025 / For 25 years, the award-winning Arthritis Foundation California Coast Classic Bike Tour has been a cornerstone event for cyclists and arthritis ...

The vaccine candidate is being evaluated in a ring vaccination trial as part of a comprehensive public health response NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / The first participants ...

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global marketFirst-in-human Phase 1/1b single/multiple dose study in ...

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...